This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin degludec pens (U-100, 3 mL). The contract is a delivery order with a firm fixed price of $1,288.93 and a completion date of May 13, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,178.00 and covers the procurement of Insulin Degludec Pen (U-200) 3ML, a specialty medication. The contract has an ultimate completion date of October 16, 2023 and is a firm fixed price delivery order contract. This award is associated with a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,710.72 firm fixed price contract is for the supply of insulin degludec pens (U-100, 3 mL) to support military treatment facilities and federal healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp's Corporate Office Division. The $3,612.60 firm fixed-price contract is for the delivery of Insulin Degludec Pens (U-100) 3ML, a critical medical supply. The contract has no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery Contract...
The U.S. Department of Defense (DOD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,184,917 units of Insulin Degludec Pens (U-200) 3ML. The contract, valued at $4,137.57, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by the...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,930.60, is for the procurement of insulin degludec pens (U-200) in 3 milliliter sizes. The contract is a firm-fixed price delivery order with a completion date of February 20, 2024. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Glargine-yfgn U100 Pen 3ML. The contract has a Ceiling Value of $1,575.60 and runs through January 28, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Insulin Degludec Pen (U-200) 3ML, a specialty medication used for diabetes management. The firm-fixed-price contract has a ceiling value of $4,417.19 and runs through January 2, 2025. This delivery order is part of a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,188.48 firm fixed-price contract is for the supply of insulin degludec pens (U-100, 3 mL) to support military healthcare programs. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,471.35, is for the supply of Insulin Degludec Pen (U-200) 3ML, a critical medical commodity for federal healthcare programs. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...